Loading...
•
Dec 31, 2019
Select Medical Q4 2019 Earnings Report
Reported an increase in net operating revenues, income from operations, and net income compared to the same quarter prior year.
Key Takeaways
Select Medical Holdings Corporation announced its Q4 2019 results, with net operating revenues increasing by 8.7% to $1,374.6 million, income from operations increasing by 27.3% to $112.4 million, and net income increasing by 46.9% to $43.7 million compared to the same quarter of the prior year. Adjusted EBITDA increased by 16.9% to $171.9 million, and adjusted earnings per common share was $0.31 on a fully diluted basis.
Net operating revenues increased by 8.7% to $1,374.6 million compared to Q4 2018.
Income from operations increased by 27.3% to $112.4 million compared to Q4 2018.
Net income increased by 46.9% to $43.7 million compared to Q4 2018.
Adjusted earnings per common share was $0.31 on a fully diluted basis, compared to $0.20 for the same quarter, prior year.
Select Medical
Select Medical
Select Medical Revenue by Segment
Revenue by Segment
Critical Illness Recovery Hospital Revenue
CapyFin.comRehabilitation Hospital Revenue
CapyFin.comOutpatient Rehabilitation Revenue
CapyFin.com Forward Guidance
Select Medical reaffirms its 2020 business outlook for net operating revenues, Adjusted EBITDA and fully diluted earnings per common share.
Positive Outlook
- Consolidated net operating revenues for the full year 2020 are expected to be in the range of $5.575 billion to $5.675 billion.
- Adjusted EBITDA for the full year 2020 is expected to be in the range of $725.0 million to $760.0 million.
- Fully diluted earnings per common share for the full year 2020 are expected to be in the range of $1.27 to $1.46.
Revenue & Expenses
Visualization of income flow from segment revenue to net income